Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIPASA-TWO: Antibiotics vs Surgery for Appendicitis
NCT03169114Terminated
- Sponsor
- RIPAS Hospital
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amikacin and ciprofloxacin in appendicitis, sponsored by RIPAS Hospital. Primary endpoint: Number of cases of treatment failures at 30 days. Started Nov 2017; status: terminated.
02
Drugs
amikacinciprofloxacin
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT03169114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03169114.